NCT00001573View on ClinicalTrials.gov

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 1997

Study Completion Date

May 31, 2000

Conditions

GliomaSarcoma

Interventions

DRUG

SU101

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH